Israel Englander’s Avidity Biosciences RNAM Stock Holding History

Israel Englander’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-258,000	Closed	-$18.6M	–	6286
2025 Q4	$18.6M	Buy	258,000 +250,100	+3,166%	+$16.2M	0.01%	1646
2025 Q3	$344K	Sell	7,900 -7,100	-47%	-$287K	﹤0.01%	5282
2025 Q2	$426K	Hold	15,000	–	–	﹤0.01%	4996
2025 Q1	$443K	Buy	+15,000	New	+$467K	﹤0.01%	4888

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Israel Englander's RNAM Position: Q1 2026 in Review

Israel Englander sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,157,270 shares — an estimated $156M sold.

Israel Englander first reported a position in RNAM in Q2 2020 and held it in 19 quarters. The position peaked at $156M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Israel Englander reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Israel Englander sold 2,157,270 Avidity Biosciences shares in Q1 2026, an estimated $156M.
Israel Englander first reported a position in Avidity Biosciences in Q2 2020 and held it in 19 quarters.
Israel Englander's Avidity Biosciences position peaked at $156M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.